Medical News

RSS

Sildenafil plus recreational drugs equals risky sexual behaviour

A new survey has found that a significant number of young men have used erectile dysfunction, (ED), medications such as Viagra often in conjunction with other recreational drugs, and most without consulting a physician.

1 May 2006

A contraceptive pill for men!

According to a Sydney scientist a hormone-based contraceptive for men has the ability to reverse its effect just four months after stopping its use.

1 May 2006

Oh what a feeling!

Just five months after the pioneering operation Isabelle Dinoire, the world's first partial face transplant says she now has complete feeling in the new tissue on her face.

1 May 2006

Former FDA commissioner investigated

It appears that the former commissioner of the Food and Drug Administration Dr. Lester Crawford is under federal investigation amid accusations of financial improprieties and making false statements to Congress.

1 May 2006

Combo of testing and vaccines a winner in fight against cervical cancer

According to experts in reproductive health, the combination of HPV testing with HPV vaccines is the best hope for preventing cervical cancer.

1 May 2006

New drug to treat rare Pompe disease gets FDA approval

The Food and Drug Administration in the U.S. has given approval for the first drug to treat a rare, debilitating muscle disease that can kill infants within a year.

1 May 2006

Bird flu hits British farms

According to British environment officials a strain of bird flu has now been detected at three poultry farms at North Tuddenham, near Norwich, Norfolk. Norfolk has some of Europe's biggest poultry farms.

1 May 2006

New method found showing how nerve cells can selectively filter and transfer signals

Scientists from Gvttingen and Bochum find evidence for a new mechanism, with which our nerve cells are able to filter signals and transfer them selectively.

28 Apr 2006

New method could predict individual patient responses to drug treatments

Scientists from Imperial College London and Pfizer have developed a new method that could predict individual patient responses to drug treatments. The authors anticipate that the development will advance biomedical research further towards development of personalised medicines.

28 Apr 2006

Method by which Caspase-12 shuts down the body's immune system discovered

Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.

28 Apr 2006

Visual word forming area (VWFA) of the cortex demonstrated to have an effect on word recognition

Humans have an uncanny ability to skim through text, instantly recognizing words by their shape--even though writing developed only about 6000 years ago--long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.

28 Apr 2006

Human brain observed to shut down 'self'

Everybody has experienced a sense of "losing oneself" in an activity--whether a movie, sport, sex, or meditation. Now, researchers have caught the brain in the act of losing "self" as it shuts down introspection during a demanding sensory task. New findings show that self-related function actually shuts down during such intense sensory tasks.

28 Apr 2006

New theory on how the brain detects motion

Researchers at the Salk Institute for Biological Studies have discovered a neural circuit that is likely to play an important role in the visual perception of moving objects. Their finding, published in the April issue of the journal Neuron, forces neurobiologists to rethink the neural pathways that our brain relies on to detect motion.

28 Apr 2006

Tumour specific drugs may render therapies based on a tumor's anatomical location obsolete

The results of a new study at Washington University School of Medicine in St. Louis could eventually have oncologists removing their specialties from their shingles by making therapy based on a tumor's anatomical location obsolete.

28 Apr 2006

Amyloid protein content in the brain linked to Alzheimer's disease risk

Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the University of Antwerp are the first to show that the quantity of amyloid protein in brain cells is a major risk factor for Alzheimer's disease. Amyloid protein has already been known to be the primary component of the senile plaques in the brains of patients. The new discovery demonstrates that the greater the quantity of the protein that is produced, the younger the dementia patient is.

28 Apr 2006

HCM detection rates doubled when genetic testing and imaging information are combined

Currently that genetic test correctly detects HCM only 40 percent of the time. But coupled with imaging information, the detection power of the test nearly doubles, to 79 percent, says Steve Ommen, M.D., director of Mayo's HCM Clinic and co-lead investigator of the Mayo Clinic research team.

28 Apr 2006

Ancient rodent DNA being used to identify the cause of its low genetic diversity

A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.

28 Apr 2006

UK's reduced health inequality targets more likely to benefit the rich

UK targets to reduce health inequalities could end up improving the health of the richest fastest, warn researchers in this week's BMJ.

28 Apr 2006

Economic benefit of federally finded clinical trials exceeds $15 billion

A comprehensive review of all phase III clinical trials supported by one Federal agency finds that, estimated conservatively, the economic benefit in the United States from just eight of these trials exceeded $15 billion over the course of 10 years. The study also found that new discoveries from the trials were responsible for an estimated additional 470,000 healthy years of life. The clinical trials were sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).

28 Apr 2006